Diabetic Retinopathy: Assessing the Armamentarium for Improved Detection and Treatment

0.75 CME
$0 FEE
Diabetic Retinopathy OG Image Size


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by an educational grant from Genentech, Inc.

Target Audience

The intended audience for the activity is comprehensive ophthalmologists and other health care professionals involved in the treatment of patients with diabetic retinopathy.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Utilize imaging techniques that aid in the early diagnosis, assessment, and monitoring of diabetic retinopathy.
  • Incorporate evidence-based medical therapy that has been shown to improve the treatment of diabetic retinopathy.

Activity Chair

Nathan C. Steinle, MD
California Retina Consultants
Santa Barbara, CA


Andrew A. Moshfeghi, MD, MBA
Director, Vitreoretinal Surgery & Medical Retina Fellowships
Director, Clinical Trials Unit
Associate Professor of Ophthalmology
USC Roski Eye Institute
Keck School of Medicine
University of Southern California
Los Angeles, CA

Carl D. Regillo, MD, FACS
Director, Retina Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Philadelphia, PA


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, April 12, 2019 through April 11, 2020.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view content, and complete the CME posttest and evaluation. Provide only one (1) answer for each question. A satisfactory score is defined as answering 2 out of 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty report the following relationship(s)

Andrew A. Moshfeghi, MD, MBA
Consulting Fee: Alcon, Allegro, Allergan, Clearside, EyePoint, Genentech/Roche, Novartis, Pr3vent, Regeneron, Valeant/Bausch + Lomb
Contracted Research: Genentech/Roche, Regeneron
Ownership Interest: OptiSTENT, Pr3vent, Visunex

Carl D. Regillo, MD, FACS
Consulting Fee: Allegro, Genentech, Iconic, Kodiak, Merck, Notal Vision, Novartis, Santen, Shire, Teva
Contracted Research: Aerpio, Allergan, Astellas, Genentech, Iconic, Novartis, Ophthea, Ophthotech, Regeneron

Nathan C. Steinle, MDConsulting Fee: Genentech
Speakers Bureau: Genentech
Contracted Research: Genentech

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com